Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
V Technology, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.9 times, Oct-Dec Ordinary Profit Increases by 2.5 times
7717 V Technology Co., Ltd. 【J-GAAP】
Earnings ReportV Technology Co., Ltd. <7717> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) surged 3.9 times that of the same period last year, reaching 0.75 billion yen. However, Progress toward the full-year plan of 4.20 billion yen was 18.0%, also falling below the five-year average of 45.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 2.0 times that of the same period last year, reaching 3.44 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.5 times that of the same period last year, reaching 1.16 billion yen. The operating profit margin drastically improved from 2.0% in the same period last year to 8.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 19,103 | -2,077 | -1,900 | -1,387 | -143.6 | ー | Feb 9, 2024 | J-GAAP |
| Apr - Dec, 2024 | 31,824 | 56 | 194 | 53 | 5.6 | 10.3 | Feb 10, 2025 | J-GAAP |
| Apr - Dec, 2025 | 32,057 | 627 | 755 | 1,304 | 138.0 | 18.0 | Feb 10, 2026 | J-GAAP |
| YoY | +0.7% | +1,019.6% | +289.2% | +2,360.4% | +2,351.9% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 23,837 | 1,957 | 2,166 | 1,018 | 107.0 | 40 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 36,256 | 4,870 | 4,606 | 2,939 | 310.9 | 40 | Nov 12, 2025 | J-GAAP |
| YoY | +52.1% | +148.9% | +112.7% | +188.7% | +190.6% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 37,335 | 846 | 1,112 | 778 | 80.7 | 60 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 46,182 | 1,821 | 1,891 | 800 | 84.1 | 80 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 56,000 | 4,500 | 4,200 | 2,700 | 285.6 | 80 | May 13, 2025 | J-GAAP |
| YoY | +21.3% | +147.1% | +122.1% | +237.5% | +239.7% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 9,479 | 192 | 469 | 271 | 28.8 | 2.0 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 14,358 | 1,765 | 1,697 | 747 | 78.5 | 12.3 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 7,998 | -514 | -589 | -665 | -70.5 | -6.4 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 11,746 | 144 | 183 | 426 | 45.2 | 1.2 | Nov 12, 2025 | J-GAAP |
| Oct - Dec, 2025 | 12,313 | 997 | 1,161 | 1,543 | 163.3 | 8.1 | Feb 10, 2026 | J-GAAP |
| YoY | +29.9% | +419.3% | +147.5% | +469.4% | +467.3% |
Related Articles
GMO Research&AI, 2.0 times Increase in Ordinary Profit, Record High for The First Time in Four Years, Dividend Raised by 4.69 Yen
Choei, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%, Oct-Dec Ordinary Profit Increases by 3.4 times
VIS, Oct-Dec (3Q) Ordinary Profit Increases by 20%
Shinnihonseiyaku, Oct-Dec (1Q) Ordinary Profit Decreases by 1%
Sharp, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 16%
Shiseido, Returning to Profitability This Year, Dividend Raised by 20 Yen
OTANI KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Exceeds Full-Year Plan
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
OHASHI TECHNICA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 22%, Oct-Dec Ordinary Profit Increases by 29%
KAPPA CREATE, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 38%, Oct-Dec Ordinary Profit Turns to Loss